Targeting regulatory T cells in vaccination: In silico identified small molecule CCR4 antagonists exert adjuvant activity

被引：0

作者：

Bayr, Jagadeesh ^{[1
,2
]}

Tchilian, Elma Z. ^{[3
]}

Davies, Matthew N. ^{[2
]}

Beverley, Peter C. L. ^{[2
,3
]}

Flower, Darren R. ^{[2
]}

Tough, David F. ^{[2
,4
]}

机构：

[1] INSERM, U872, Ctr Rech Cordeliers, Paris, France

[2] Univ Oxford, Edward Jenner Inst Vaccine Res, Compton, England

[3] Univ Oxford, Oxford, England

[4] GlaxoSmithKline, Stevenage, Herts, England

来源：

JOURNAL OF IMMUNOLOGY | 2009年 / 182卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

96.12

引用

页数：1

共 50 条

[1] In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination
Bayry, Jagadeesh
Tchilian, Elma Z.
Davies, Matthew N.
Forbes, Emily K.
Draper, Simon J.
Kaveri, Srini V.
Hill, Adrian V. S.
Kazatchkine, Michel D.
Beverley, Peter C. L.
Flower, Darren R.
Tough, David F.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (29) : 10221 - 10226
[2] Small molecule antagonists of the CC chemokine receptor 4 (CCR4)
Burdi, Douglas F.
Chi, Shannon
Mattia, Karen
Harrington, Celeste
Shi, Zhan
Chen, Shaowu
Jacutin-Porte, Swanee
Bennett, Robert
Carson, Kenneth
Yin, Wei
Kansra, Vikram
Gonzalo, Jose-Angel
Coyle, Anthony
Jaffee, Bruce
Ocain, Timothy
Hodge, Marty
LaRosa, Gregory
Harriman, Geraldine
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (11) : 3141 - 3145
[3] Small-Molecule CCR4 Antagonists in Cutaneous T-cell Lymphoma
Enriquez, Jose S.
Wang, Xiaohong
Velatooru, Loka Reddy
Han, Wei
Bijani, Pedram
Ni, Xiao
CANCER RESEARCH COMMUNICATIONS, 2024, 4 (10): : 2756 - 2765
[4] Small Molecule CCR4 Antagonists Protect Mice from Aspergillus Infection and Allergy
Bozza, Silvia
Iannitti, Rossana Giulietta
Pariano, Marilena
Renga, Giorgia
Costantini, Claudio
Romani, Luigina
Bayry, Jagadeesh
BIOMOLECULES, 2021, 11 (03) : 1 - 12
[5] Effects of CCR4 antagonists in cutaneous T-cell lymphoma cells
Enriquez, J. S.
Bijani, P.
Duvic, M.
Ni, X.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S80 - S80
[6] EBV associated tumors have increased regulatory T cell recruitment and are therefore a potential indication for treatment with potent and selective small molecule CCR4 antagonists
Talay, Oezcan
Jorapur, Aparna
Jacobson, Scott
Marubayashi, Sachie
Marshall, Lisa
Suthram, Silpa
Robles, Omar
Ketcham, John
Reilly, Maureen K.
Younai, Ashkaan
Biannic, Berenger
Hu, Dennis
Bui, Minna
Schwarz, Jacob
Kassner, Paul
Cutler, Gene
CANCER RESEARCH, 2018, 78 (13)
[7] Absence of CCR4 enhances the function of expanded regulatory T-cells
Coghill, James M.
Seidel, Hans
Serody, Jonathan S.
BLOOD, 2007, 110 (11) : 646A - 646A
[8] North American Adult T-Cell Leukemia/Lymphoma Has Frequent Mutations in CCR4 and Responds in Vitro to a Small Molecule CCR4 Antagonist, CCR4-351
Ye, B. Hilda
Liu, Eric
Pradhan, Kith
Guillen, Erik
Shah, Urvi A.
Shastri, Aditi
Lauvau, Gregoire
Janakiram, Murali
Sica, Alejandro
Kassner, Paul D.
Verma, Amit
BLOOD, 2023, 142
[9] The role of regulatory T cells in the resistence of CCR4 knockout mice during severe sepsis
Benjamim, Claudia
Molinaro, R.
Franca, A.
Bozza, M.
Cunha, F.
Kunkel, S.
INFLAMMATION RESEARCH, 2007, 56 : S399 - S399
[10] Role of Chemokine Receptor CCR4 and Regulatory T Cells in Wound Healing of Diabetic Mice
Barros, Janaina F.
Waclawiak, Ingrid
Pecli, Cyntia
Borges, Paula A.
Georgii, Janaina L.
Ramos-Junior, Erivan S.
Canetti, Claudio
Courau, Tristan
Klatzmann, David
Kunkel, Steven L.
Penido, Carmen
Canto, Fabio B.
Benjamim, Claudia F.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : 1161 - 1170

← 1 2 3 4 5 →